AU2010204766B2 - Methods for improving hepatic and immune function in an animal - Google Patents

Methods for improving hepatic and immune function in an animal Download PDF

Info

Publication number
AU2010204766B2
AU2010204766B2 AU2010204766A AU2010204766A AU2010204766B2 AU 2010204766 B2 AU2010204766 B2 AU 2010204766B2 AU 2010204766 A AU2010204766 A AU 2010204766A AU 2010204766 A AU2010204766 A AU 2010204766A AU 2010204766 B2 AU2010204766 B2 AU 2010204766B2
Authority
AU
Australia
Prior art keywords
lipoic acid
ppm
composition
salt
immune function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010204766A
Other languages
English (en)
Other versions
AU2010204766A1 (en
Inventor
Inke Paetau-Robinson
Steven C. Zicker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hills Pet Nutrition Inc
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of AU2010204766A1 publication Critical patent/AU2010204766A1/en
Application granted granted Critical
Publication of AU2010204766B2 publication Critical patent/AU2010204766B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010204766A 2009-01-14 2010-01-14 Methods for improving hepatic and immune function in an animal Active AU2010204766B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/353,351 2009-01-14
US12/353,351 US20090176864A1 (en) 2004-11-24 2009-01-14 Methods For Improving Hepatic and Immune Function In An Animal
PCT/US2010/020993 WO2010083277A2 (en) 2009-01-14 2010-01-14 Methods for improving hepatic and immune function in an animal

Publications (2)

Publication Number Publication Date
AU2010204766A1 AU2010204766A1 (en) 2011-07-21
AU2010204766B2 true AU2010204766B2 (en) 2013-01-31

Family

ID=42124569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010204766A Active AU2010204766B2 (en) 2009-01-14 2010-01-14 Methods for improving hepatic and immune function in an animal

Country Status (12)

Country Link
US (2) US20090176864A1 (ja)
EP (1) EP2387325B1 (ja)
JP (1) JP5791520B2 (ja)
CN (2) CN106036037A (ja)
AU (1) AU2010204766B2 (ja)
BR (1) BRPI1007294A2 (ja)
CA (2) CA2749280C (ja)
DK (1) DK2387325T3 (ja)
ES (1) ES2603986T3 (ja)
RU (1) RU2485797C2 (ja)
WO (1) WO2010083277A2 (ja)
ZA (1) ZA201104624B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
WO2006071919A2 (en) 2004-12-29 2006-07-06 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1906912B1 (en) * 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
WO2011008800A1 (en) * 2009-07-14 2011-01-20 Hill's Pet Nutrition, Inc. Pet food compositions including a sustained-release lipoic acid and methods of manufacture and use thereof
CN102657297A (zh) * 2012-05-30 2012-09-12 扬州大学 一种调控高产奶牛围产期氧化应激的方法
WO2021243093A1 (en) * 2020-05-27 2021-12-02 Immunoflex Therapeutics Inc. Methods and compositions for treating and recovering form viral infections

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621117A (en) * 1994-07-30 1997-04-15 Asta Medica Aktiengesellschaft Method for the racemization of enantiomers of α-lipoic acid
US5994393A (en) * 1998-03-11 1999-11-30 Asta Medica Aktiengesellschaft Alpha-lipoic acid with novel modification
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20020076469A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20030224061A1 (en) * 2002-06-04 2003-12-04 Pacioretty Linda M. Oral composition with insulin-like activities and methods of use
US20040138311A1 (en) * 2001-05-28 2004-07-15 Michael Taeger Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus
US20050123628A1 (en) * 2003-12-03 2005-06-09 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
US6914071B2 (en) * 2000-10-31 2005-07-05 Colgate-Palmolive Company Antioxidant containing composition and method
WO2006058248A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
KR20060072603A (ko) * 2004-12-23 2006-06-28 한서제약 주식회사 α-리포산 함유 간질환 예방 또는 치료용 조성물
KR20070025426A (ko) * 2005-09-02 2007-03-08 부광약품 주식회사 Ｄ-(+)-α-리포산 트로메타민염을 포함하는 간섬유화 억제 및 치료용 조성물

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2980716A (en) * 1954-06-11 1961-04-18 Research Corp Method for preparing 6, 8-dihalooctanoic esters
US2890716A (en) * 1956-03-16 1959-06-16 Buensod Stacey Inc Control device
US3202514A (en) * 1963-07-15 1965-08-24 Gen Foods Corp Animal food and method of making the same
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
US3946123A (en) * 1975-03-10 1976-03-23 Star-Kist Foods, Inc. Canned pet food
US4053647A (en) * 1975-12-12 1977-10-11 Samuel Prussin Pet food product and process of producing such
US4247562A (en) * 1978-12-21 1981-01-27 The Quaker Oats Company Moist pet food with blood chunks and a fluid gravy system
DE3378909D1 (en) * 1982-10-20 1989-02-16 Takeda Chemical Industries Ltd Physiologically active substance p-23924, its production and use
US5004624A (en) * 1983-03-14 1991-04-02 Star-Kist Foods, Inc. Semi-moist pet food having free gravy and process for preparation thereof
AU601992B2 (en) * 1986-06-21 1990-09-27 Dainippon Ink And Chemicals Inc. Isoliquiritigenin for the treatment of kidney and liver diseases
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
US4997672A (en) * 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
EP0326034B1 (de) * 1988-01-28 1992-08-26 Peter Dr. Költringer Kombinationspräparat zur Behandlung von Nervenzell-und Nervenfasererkrankungen und Verletzungen
US6977167B2 (en) * 1988-09-07 2005-12-20 Martek Biosciences Corporation Mixtures of omega-3 and omega-6 highly unsaturated fatty acids from euryhaline microorganisms
US4997671A (en) * 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US5114704A (en) * 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
EP0427247B1 (de) * 1989-11-09 1998-03-11 ASTA Medica Aktiengesellschaft Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US5419283A (en) * 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4235912C2 (de) * 1992-10-23 2002-12-05 Viatris Gmbh Verfahren zur Herstellung kristalliner Thioctsäure und deren Verwendung
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
US5532010A (en) * 1993-05-28 1996-07-02 Nabisco, Inc. Coated canine biscuits and preparation process
US5339771A (en) * 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
CA2176709A1 (en) * 1993-11-15 1995-05-26 Howard R. Higley Method of treating renal disease by administering igf-i and igfbp-3
US6458767B1 (en) * 1994-05-04 2002-10-01 The Uab Research Foundation Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease
US5599835A (en) * 1994-11-23 1997-02-04 Fischer; Frederick B. Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus
US5621177A (en) * 1995-03-02 1997-04-15 Yokogawa Electric Corporation Electromagnetic flowmeter
US5730988A (en) * 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
CA2208392C (en) * 1996-06-21 2002-09-03 University Of Guelph Method for enriching docosahexaenoic acid in expressed milk of dairy cattle
US5965596A (en) * 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
WO1998018610A1 (en) * 1996-10-28 1998-05-07 Lengerich Bernhard H Van Embedding and encapsulation of controlled release particles
US6232346B1 (en) * 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
US5883083A (en) * 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
US6039952A (en) * 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
US6365623B1 (en) * 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
US6117477A (en) * 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
DE19834608A1 (de) * 1998-07-31 2000-02-03 Basf Ag Kristallmodifikation der Liponsäure
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US20040029175A1 (en) * 1998-12-21 2004-02-12 Comper Wayne D. Method for kidney disease detection
WO2000037944A1 (en) * 1998-12-21 2000-06-29 Monash University Kidney disease detection and treatment
AUPP784398A0 (en) * 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
US6284786B1 (en) * 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
DE60018225T2 (de) * 1999-03-01 2005-12-29 Pfizer Products Inc., Groton Oxamsäuren mit einer Cyanogruppe als Liganden für den Thyroidrezeptor
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
BR0010999A (pt) * 1999-05-27 2002-02-19 Iams Company Processo e produto para melhorar a resposta imunológica em um animal de companhia, processos para optimizar células imunes em um cão e para optimizar o reconhecimento da vacina em um cão, e, produto de ração para animal doméstico para melhorar a resposta imunológica em um animal de companhia
US6365211B1 (en) * 1999-06-18 2002-04-02 The Procter & Gamble Co. Cooking aid with reduced foaming
US6426362B1 (en) * 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
NZ518739A (en) * 1999-11-02 2004-12-24 Depomed Inc Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
US6335361B1 (en) * 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6379727B1 (en) * 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
US20030060503A1 (en) * 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
CZ20022927A3 (cs) * 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
JP4487376B2 (ja) * 2000-03-31 2010-06-23 味の素株式会社 腎疾患治療剤
US7067145B2 (en) * 2000-09-07 2006-06-27 University Of Maryland Biotechnology Institute Use of arachidonic acid for enhanced culturing of fish larvae and broodstock
US6784159B2 (en) * 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
CA2427470A1 (en) * 2000-10-31 2002-06-06 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function
US8592479B2 (en) * 2000-10-31 2013-11-26 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
US20090156658A1 (en) * 2000-10-31 2009-06-18 Hill's Pet Nutrition, Inc. Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals
US20020052402A1 (en) * 2000-10-31 2002-05-02 Colgate-Palmolive Company Composition and method
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
WO2002052951A1 (en) * 2000-12-29 2002-07-11 Martin Francis Gannon An animal food product
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
WO2002071874A2 (en) * 2001-03-09 2002-09-19 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
JP2004526458A (ja) * 2001-05-14 2004-09-02 マーテック・バイオサイエンシーズ・コーポレーション 飼鳥肉の風味、軟らかさ、および全消費者嗜好性の改善法
US6596762B2 (en) * 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
US6596768B2 (en) * 2001-05-22 2003-07-22 Church & Dwight Co., Inc. Unsaturated lipid-enriched feedstock for ruminants
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
GB0119052D0 (en) * 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20030194478A1 (en) * 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
EP1633768A2 (en) * 2003-05-13 2006-03-15 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
US7202270B2 (en) * 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
WO2006012267A1 (en) * 2004-06-29 2006-02-02 Elixirin Corporation Dietary compositions for enhancing metabolism and reducing reactive oxygen species
US20060002985A1 (en) * 2004-07-02 2006-01-05 Zicker Steven C Compositions and methods for decreasing age-related deterioration in mental activities in companion animals
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
WO2006071919A2 (en) * 2004-12-29 2006-07-06 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
EP1906912B1 (en) * 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
AU2006279429B2 (en) * 2005-08-17 2010-02-25 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621117A (en) * 1994-07-30 1997-04-15 Asta Medica Aktiengesellschaft Method for the racemization of enantiomers of α-lipoic acid
US5994393A (en) * 1998-03-11 1999-11-30 Asta Medica Aktiengesellschaft Alpha-lipoic acid with novel modification
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20020076469A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US6914071B2 (en) * 2000-10-31 2005-07-05 Colgate-Palmolive Company Antioxidant containing composition and method
US20040138311A1 (en) * 2001-05-28 2004-07-15 Michael Taeger Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus
US20030224061A1 (en) * 2002-06-04 2003-12-04 Pacioretty Linda M. Oral composition with insulin-like activities and methods of use
US20050123628A1 (en) * 2003-12-03 2005-06-09 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
WO2006058248A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
KR20060072603A (ko) * 2004-12-23 2006-06-28 한서제약 주식회사 α-리포산 함유 간질환 예방 또는 치료용 조성물
KR20070025426A (ko) * 2005-09-02 2007-03-08 부광약품 주식회사 Ｄ-(+)-α-리포산 트로메타민염을 포함하는 간섬유화 억제 및 치료용 조성물

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CUI, J. et al., Cellular Immunology, 2009, 260, 44-50 *
LEY, B. M., http://web.archive.org/web/20000614235007/http://www.tldp.com/issue/160/160alpha.htm, 14 June 2000 *
OHMORI, H. et al., Japan J. Pharmacol., 1986, 42, 275-280 *

Also Published As

Publication number Publication date
JP5791520B2 (ja) 2015-10-07
WO2010083277A2 (en) 2010-07-22
ES2603986T3 (es) 2017-03-02
BRPI1007294A2 (pt) 2015-08-25
CN102281769A (zh) 2011-12-14
CA2843448A1 (en) 2010-07-22
ZA201104624B (en) 2015-02-25
US20110135785A1 (en) 2011-06-09
WO2010083277A3 (en) 2011-01-06
US20090176864A1 (en) 2009-07-09
RU2485797C2 (ru) 2013-06-27
AU2010204766A1 (en) 2011-07-21
DK2387325T3 (en) 2016-12-05
CN106036037A (zh) 2016-10-26
JP2012515211A (ja) 2012-07-05
RU2011134077A (ru) 2013-02-20
CA2749280C (en) 2014-05-06
CA2749280A1 (en) 2010-07-22
EP2387325A2 (en) 2011-11-23
EP2387325B1 (en) 2016-08-17

Similar Documents

Publication Publication Date Title
AU2010204766B2 (en) Methods for improving hepatic and immune function in an animal
Baetz et al. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
Sadahira et al. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.
Alvarez et al. ER to Golgi transport: requirement for p115 at a pre-Golgi VTC stage
Nau The methylation of tRNA
Kirchhoff et al. Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation
Reid et al. Red blood cell blood group antigens: structure and function
Piller et al. Comparison of the carbohydrate‐binding specificities of seven N‐acetyl‐D‐galactosamine‐recognizing lectins
Niehaus et al. Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration
Hwang et al. Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons
Wuytack et al. The Ca 2+-transport ATPases from the plasma membrane
Weerth et al. Signaling proteins in raft-like microdomains are essential for Ca2+ wave propagation in glial cells
Gibbs et al. Glioma pathogenesis-related 1-like 1 is testis enriched, dynamically modified, and redistributed during male germ cell maturation and has a potential role in sperm-oocyte binding
Bast et al. Idiotypic peripheral blood lymphocytes in monoclonal gammopathy
Lawrence et al. Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes
Tiengwe et al. Surface proteins, ERAD and antigenic variation in Trypanosoma brucei
Shigeri et al. Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line.
Choi et al. Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells
Van Lier et al. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways
Foster et al. Markers of the metastatic phenotype in prostate cancer
Piontek et al. Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: evidence that gravin provides a dynamic platform for the localization of kinases during neuronal development
Kissmehl et al. Subplasmalemmal Camstores in Paramecium tetraurelia. Identification and characterisation of a sarco (endo) plasmic reticulum-like Ca2+-ATPase by phosphoenzyme intermediate formation and its inhibition by caffeine
Mahabaleshwar et al. Slit‐Robo signalling establishes a Sphingosine‐1‐phosphate gradient to polarise fin mesenchyme
Walaas et al. Phosphorylation of multiple sites in a 15 000 dalton proteolipid from rat skeletal muscle sarcolemma, catalyzed by adenosine 3′, 5′-monophosphate-dependent and calcium/phospholipid-dependent protein kinases
Pain Protein synthesis in a postmitochondrial supernatant system from rat liver. An effect of diabetes at the level of peptide chain initiation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)